https://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366(21)00241-8/fulltext
Interpretation
Long-term exposure to prolactin-increasing, but not to prolactin-sparing, antipsychotics is significantly associated with increased odds of breast cancer. Monitoring prolactinemia and addressing hyperprolactinemia is paramount in women with schizophrenia being treated with prolactin-increasing antipsychotics